序号 |
|
主题 |
跟贴/点击 |
作者 |
最后回复 |
提示 |
● 药厂相关职位内推-汇总(JNJ, Takeda, Pfizer, GSK) (486b)
|
-- | tlexander 2021-08-27 | -- |
提示 |
● 国内Biotech/Pharma开在美国的分部 (309b)
|
-- | benbenx 2021-06-29 | -- |
3 |
|
● 现在是跳槽去biotech的好时机么 (169b)
|
13/361 | bostonggg 2022-06-21 | Tevez10 06-25 01:30 |
4 |
|
● 波士顿药厂形势如何? (137b)
|
9/756 | EOS 2022-06-15 | frolicsome 06-24 20:24 |
5 |
|
● 药厂non-compete格式合同,怎么对付? (311b)
|
4/508 | kingsmen 2022-06-21 | Tevez10 06-22 21:54 |
6 |
|
● Big pharma,biotech PhD以上级别 (406b)
|
8/2815 | Thymine 2022-01-11 | woailanqiu3 06-20 20:30 |
7 |
|
● 国内Biotech/Pharma开在美国的分部 (309b)
|
16/4627 | benbenx 2021-06-29 | otis 06-20 15:30 |
8 |
|
● 药厂做clinical相关的还是转cs (528b)
|
1/242 | IrisHer 2022-06-16 | yaji 06-19 14:15 |
9 |
|
● 同感找第一份工业界的工作不容易 (363b)
|
15/2260 | ddbl 2022-06-14 | tlexander 06-19 13:21 |
10 |
|
● Genetics和Genomics主要的几个big pharma的对等机构 (262b)
|
0/90 | tlexander 2022-06-19 | -- |
11 |
|
● Johnson & Johnsonn长期职位内推 (556b)
|
15/1561 | tlexander 2022-05-15 | Yupu95 06-18 22:14 |
12 |
|
● 怎么又被一堆十万个为什么给刷屏了 (68b)
|
0/88 | yaji 2022-06-18 | -- |
13 |
|
● 群里做hit-finding,可以关注一下CACHE项目 (321b)
|
0/49 | tlexander 2022-06-18 | -- |
14 |
|
● Multiple Myeloma的market很大吗?为什么这么多药厂 (77b)
|
0/66 | tlexander 2022-06-18 | -- |
15 |
|
● R package for real-word evidence analysis,真实世 (62b)
|
1/77 | tlexander 2022-06-18 | tlexander 06-18 21:08 |
16 |
|
● Astrazeneca有中国人的wechat群吗? (34b)
|
0/70 | tlexander 2022-06-18 | -- |
17 |
|
● 肺癌患者 Osimertinib 奥希替尼耐药后一般该怎么办? (50b)
|
1/34 | tlexander 2022-06-18 | tlexander 06-18 20:43 |
18 |
|
● 肺癌患者如何确定是否发生了对侧淋巴灶转移?? (45b)
|
1/21 | tlexander 2022-06-18 | tlexander 06-18 20:13 |
19 |
|
● protein engineering在大药厂一般处于食物链的哪个环 (133b)
|
0/43 | tlexander 2022-06-18 | -- |
20 |
|
● 有 biopharma/biotech/pharma 的微信群吗?? (22b)
|
7/794 | aqqq 2021-12-24 | tlexander 06-18 20:10 |
21 |
|
● 肺癌治疗基本原则?开刀 -> 靶向 -> PD1/PDL1 (113b)
|
4/48 | tlexander 2022-06-18 | tlexander 06-18 20:09 |
22 |
|
● PD1,PDL1,对身体素质要求很高啊? (89b)
|
0/34 | tlexander 2022-06-18 | -- |
23 |
|
● 肺癌患者,EGFR和TP53双突变。问题: 手术 vs PD-1 v (85b)
|
2/26 | tlexander 2022-06-18 | tlexander 06-18 19:57 |
24 |
|
● 靶向药物一般10-18个月耐药,为何一定要耐药?机制是 (62b)
|
0/29 | tlexander 2022-06-18 | -- |
25 |
|
● mantle cell lymphoma (MCL)的market竞争激烈吗? (54b)
|
0/19 | tlexander 2022-06-18 | -- |
26 |
|
● Cetrelimab, a PD-1 Inhibitor 联合BALVERSA FGFR in (334b)
|
0/58 | tlexander 2022-06-18 | -- |
27 |
|
● 合成对照臂(synthetic control arm)现在大范围应用 (56b)
|
0/20 | tlexander 2022-06-18 | -- |
28 |
|
● Hiring bioinformatics engineer (99b)
|
1/87 | dfdong 2022-06-15 | tlexander 06-18 15:06 |
29 |
|
● 这条路走的如何:英国NHS(National Health Service, (110b)
|
0/24 | tlexander 2022-06-18 | -- |
30 |
|
● SF旁边的Newark出了一个新公司 Ultima Genomics最近 (55b)
|
1/167 | tlexander 2022-05-31 | melodywong78 06-18 02:38 |
31 |
|
● 可怜的先灵葆雅(Schering)捡到宝贝竟然丢了.. (1.1k)
|
4/786 | tlexander 2022-06-12 | tlexander 06-17 20:38 |
32 |
|
● 为什么不批量化地把人体所有酶的inhibitor一次性都开 (95b)
|
0/42 | tlexander 2022-06-17 | -- |
33 |
|
● 求比较东部药企offer(第一份工作) (740b)
|
8/1737 | focusidea2 2022-06-08 | IrisHer 06-16 21:42 |
34 |
|
● 寻找感兴趣靶点的agonist比antagonist更困难吗? (46b)
|
3/103 | tlexander 2022-06-12 | tlexander 06-14 21:53 |
35 |
|
● 针对趋化因子/趋化因子受体的药物开发怎么这么难?好 (64b)
|
2/77 | tlexander 2022-06-12 | tlexander 06-13 07:23 |
36 |
|
● Regeneron买了Checkmate获得了Vidutolimod (CMP-001) (767b)
|
1/255 | tlexander 2022-06-12 | tlexander 06-12 23:36 |
37 |
|
● Parkinson’s Disease 新药物开发进展 (166b)
|
1/96 | tlexander 2022-06-12 | tlexander 06-12 20:27 |
38 |
|
● Top25 pharma里面管线竞争度比较大的有哪几家? (45b)
|
0/180 | tlexander 2022-06-12 | -- |
39 |
|
● Abbvie的帕金森的药有特效吗?刚交了NDA, 非常期待 (48b)
|
2/149 | tlexander 2022-06-10 | fire110 06-12 13:41 |
40 |
|
● Novavax疫苗稍有增加的心肌炎及中风风险,可以理解吗 (77b)
|
1/63 | tlexander 2022-06-11 | kc2013 06-11 11:12 |
41 |
|
● Big pharma的Scientific Advisory Board的工资一般给 (56b)
|
1/227 | tlexander 2022-06-11 | kc2013 06-11 11:03 |
42 |
|
● 有些人在很多药厂的Scientific Advisory Board里面? (76b)
|
0/115 | tlexander 2022-06-11 | -- |
43 |
|
● 查看岗位薪水区间,哪些网站? (113b)
|
2/320 | fire110 2022-06-08 | Thymine 06-11 10:18 |
44 |
|
● 事实证明Alex Zhavoronkov的策略比Daphne Koller的更 (68b)
|
0/74 | tlexander 2022-06-11 | -- |
45 |
|
● 感觉vision方面GSK和Roche稍微跟强一些? (40b)
|
0/88 | tlexander 2022-06-11 | -- |
46 |
|
● high content cellular phenotype data是Daphne从201 (587b)
|
0/56 | tlexander 2022-06-10 | -- |
47 |
|
● PD1/PDL1能否拿下所有的cancer?好像现在还在一个一 (55b)
|
0/75 | tlexander 2022-06-10 | -- |
48 |
|
● keynote做stunning and memorable presentations (31b)
|
0/31 | tlexander 2022-06-10 | -- |
49 |
|
● Science朱刊发文说FDA advisers greenlight Novavax (157b)
|
1/42 | tlexander 2022-06-10 | tlexander 06-10 20:47 |
50 |
|
● CAR-T估计等通用型获批后,会大踏步前进 (146b)
|
2/104 | tlexander 2022-06-10 | Tevez10 06-10 20:46 |
51 |
|
● Bay Area的insitro,多少人知道? (32b)
|
0/49 | tlexander 2022-06-10 | -- |
52 |
|
● Bluebird的高票通过,竟然只有这么一点涟漪 (196b)
|
0/87 | tlexander 2022-06-10 | -- |
53 |
|
● 2018年的CAR-T、2020年的Tigit、2021年的双抗和PD-1 (27b)
|
0/62 | tlexander 2022-06-10 | -- |
54 |
|
● 为期2天的retreat一般是什么流程? (30b)
|
0/69 | tlexander 2022-06-10 | -- |
55 |
|
● offer咨询 (325b)
|
2/473 | BigPang123 2022-06-09 | BigPang123 06-09 16:36 |
56 |
|
● 报个senior scientist offer (235b)
|
12/2895 | qqattest 2022-06-02 | ducan21 06-06 10:06 |
57 |
|
● 请教大家一下GSK的online job simulation, powered b (143b)
|
1/151 | liufanghe 2022-06-02 | liufanghe 06-06 08:59 |
58 |
|
● droplet digital PCR (ddPCR) 现在成本怎么样? (113b)
|
0/62 | tlexander 2022-06-05 | -- |
59 |
|
● Johnson & Johnson 内推及招人 (611b)
|
2/782 | Fractal 2022-05-24 | Fractal 06-05 03:32 |
60 |
|
● Amylyx会不会成为ALS药的黑马? (246b)
|
1/275 | kingsmen 2022-06-04 | tlexander 06-04 10:50 |
61 |
|
● AAV pk LNP,LNP的免疫原型和毒性如何? (592b)
|
0/123 | tlexander 2022-06-03 | -- |
62 |
|
● 现在做pooled safety analysis (PDF)&# (70b)
|
0/42 | tlexander 2022-06-03 | -- |
63 |
|
● AAV在体内的PK大概是如何的 不同血清型是否差别很大? (51b)
|
0/61 | tlexander 2022-06-02 | -- |
64 |
|
● 好像针对各种基因融合的晚期实体瘤的疗法成功率蛮高 (84b)
|
0/56 | tlexander 2022-06-02 | -- |
65 |
|
● 甲骨文买Cerner是出于什么目的?TDOC还吃香吗? (45b)
|
0/33 | tlexander 2022-06-01 | -- |
66 |
|
● PROTAC, LYTAC, AUTAC, ATTEC, RIBOTAC (15b)
|
1/90 | tlexander 2022-05-31 | tlexander 06-01 23:51 |
67 |
|
● 新公司Stock option (280b)
|
2/726 | macrophage1 2022-06-01 | uknowiknow 06-01 22:26 |
68 |
|
● BioMarin在业界到底什么地位?? (32b)
|
1/248 | tlexander 2022-05-31 | Tevez10 06-01 15:06 |
69 |
|
● HEK293的代表作品是luxtirna和zolgensma; bac/Sf9的 (290b)
|
0/134 | tlexander 2022-05-31 | -- |
70 |
|
● non-clinical saftey这个部门一般放在哪个department (56b)
|
0/44 | tlexander 2022-05-31 | -- |
71 |
|
● Pre-Clinical和Non-clinical区别?? (124b)
|
3/144 | tlexander 2022-05-31 | tlexander 05-31 18:51 |
72 |
|
● 分享一个公开的New Drug Applications (INDs)的exam (96b)
|
0/117 | tlexander 2022-05-31 | -- |
73 |
|
● 有人下周去ASMS吗? (43b)
|
0/65 | tlexander 2022-05-31 | -- |
74 |
|
● 问一个问题:对于allo cell therapy,FDA要求检测hhv (57b)
|
1/37 | tlexander 2022-05-31 | tlexander 05-31 16:16 |
75 |
|
● 求一个Pfizer的内推 (331b)
|
1/160 | MJ1992 2022-05-30 | ndpan 05-31 14:20 |
76 |
|
● BMS的Ke Xu 和 Boehringer Ingelheim的Yirong Wang (156b)
|
0/342 | tlexander 2022-05-30 | -- |
77 |
|
● IOVA的Autologous Tumor Infiltrating Lymphocytes ( (273b)
|
6/194 | tlexander 2022-05-27 | graceman 05-30 00:36 |
78 |
|
● ICI response的biomarker现在到底有没有公认的比较好 (54b)
|
0/47 | tlexander 2022-05-28 | -- |
79 |
|
● FDA关于MTD and RP2D in oncology的规定 (500b)
|
0/145 | tlexander 2022-05-28 | -- |
80 |
|
● 发个马里兰阿斯利康工作广告,如果违规请告知 (转载) (302b)
|
0/241 | zdchen 2022-05-28 | -- |
81 |
|
● 如何去做:Significant exposure to relevant regula (111b)
|
0/46 | tlexander 2022-05-28 | -- |
82 |
|
● 如何理解biomarker strategy in preclinical discove (115b)
|
0/69 | tlexander 2022-05-28 | -- |
83 |
|
● Mirati的KRAS(G12C) 有点遗憾,暴跌了 (1.5k)
|
2/536 | tlexander 2022-05-27 | trystone 05-27 22:08 |
84 |
|
● 动物模型有两种,一种是疾病模型确定MOA,一种是用来 (319b)
|
3/178 | tlexander 2022-05-27 | tlexander 05-27 18:12 |
85 |
|
● 有些靶点就是天生难对付,两个例子可以说明制药业有 (423b)
|
0/124 | tlexander 2022-05-27 | -- |
86 |
|
● 靶向TP53的药出来后能否获得诺贝尔奖?? (39b)
|
0/77 | tlexander 2022-05-27 | -- |
87 |
|
● 急问几个modified live virus做疫苗的问题! (273b)
|
0/29 | mozhe 2022-05-27 | -- |
88 |
|
● TLR9激动剂与经批准的PD-1阻断疗法相结合是靶向癌症 (69b)
|
0/41 | tlexander 2022-05-26 | -- |
89 |
|
● FDA刚刚批准了SIGA 的抗smallpox的静脉注射药物 (355b)
|
0/80 | tlexander 2022-05-25 | -- |
90 |
|
● Mpro主蛋白酶抑制剂能否开发出一个成功的光谱抗病毒 (68b)
|
0/40 | tlexander 2022-05-25 | -- |
91 |
|
● 口服3CL蛋白酶抑制剂--用于COVID-19治疗 (69b)
|
1/50 | tlexander 2022-05-24 | tlexander 05-24 23:53 |
92 |
|
● 猴痘R0<1 而 COVID的RO~7,所以还是不一样 (69b)
|
0/32 | tlexander 2022-05-24 | -- |
93 |
|
● 大药厂怎么定位R&D真是才能使得R&D对药厂的 (53b)
|
1/207 | tlexander 2022-05-24 | sharkliver 05-24 21:34 |
94 |
|
● 谁是adc主要玩家?只知道daiiichi,还有谁? (42b)
|
1/111 | tlexander 2022-05-24 | AAA2022 05-24 20:35 |
95 |
|
● 猴痘 疫苗 哪个公司在做??mRNA疫苗何时出来? (45b)
|
0/34 | tlexander 2022-05-24 | -- |
96 |
|
● Turn cold tumor into hot tumor, 有没有好的办法? (49b)
|
0/52 | tlexander 2022-05-24 | -- |
97 |
|
● 问一下,大家Relocation (Signing) Bonus大约会有多 (74b)
|
3/229 | liufanghe 2022-05-24 | trystone 05-24 16:05 |
98 |
|
● 诚心请教大佬们如何找到药厂的第一份工作 (587b)
|
6/920 | liyangelf 2022-04-14 | liufanghe 05-24 12:36 |
99 |
|
● 环状mRNA疫苗 何时进入clinical trial? (38b)
|
0/58 | tlexander 2022-05-23 | -- |
100 |
|
● 这样确实能清除COVID刺突蛋白吗? (527b)
|
5/694 | CantonLao 2022-05-21 | w567 05-22 17:38 |